EPIS_B: Adjusted EBIT improved, U.S. order intake surged, and a SEK 29.4m rights issue is planned

About this update from Episurf Medical Ab Class B

Adjusted EBIT improved by 33% year-over-year, with strong U.S. growth and cost-saving measures. A rights issue of SEK 29.4m is planned to fund FDA process completion and U.S. expansion.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Episurf Medical Ab Class B